Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Somatropin - Merck Serono

Next Previous
Search
Drug Profile

Somatropin - Merck Serono

Alternative Names: r-hGH; Saizen; Serostim; SJ 0011; Zorbtive

Latest Information Update: 08 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Merck Serono
  • Developer Bioject; Merck Serono; Savient Pharmaceuticals
  • Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
  • Mechanism of Action Human growth hormone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cachexia; Short bowel syndrome; Lipodystrophy
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cachexia; Growth disorders; Short bowel syndrome; Short stature; Somatotropin deficiency
  • Discontinued Female infertility; Lipodystrophy

Most Recent Events

  • 06 Aug 2024 AEterna Zentaris Inc is now called COSCIENS Biopharma
  • 09 Apr 2021 Discontinued - Phase-II for Female infertility (Adjunctive treatment) in Canada (SC)
  • 09 Apr 2021 Discontinued - Phase-III for Female infertility (Adjunctive treatment) in Australia (SC)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top